150 related articles for article (PubMed ID: 30998358)
1. Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.
Kumar A; Pasam VR; Thakur RK; Singh M; Singh K; Shukla M; Yadav A; Dogra S; Sona C; Umrao D; Jaiswal S; Ahmad H; Rashid M; Singh SK; Wahajuddin M; Dwivedi AK; Siddiqi MI; Lal J; Tripathi RP; Yadav PN
J Med Chem; 2019 May; 62(9):4638-4655. PubMed ID: 30998358
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents.
Ghoshal A; Kumar A; Yugandhar D; Sona C; Kuriakose S; Nagesh K; Rashid M; Singh SK; Wahajuddin M; Yadav PN; Srivastava AK
Eur J Med Chem; 2018 May; 152():148-159. PubMed ID: 29704723
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications in the distal, regulatory region of histamine H
Szczepańska K; Pockes S; Podlewska S; Höring C; Mika K; Latacz G; Bednarski M; Siwek A; Karcz T; Nagl M; Bresinsky M; Mönnich D; Seibel U; Kuder KJ; Kotańska M; Stark H; Elz S; Kieć-Kononowicz K
Eur J Med Chem; 2021 Mar; 213():113041. PubMed ID: 33261900
[TBL] [Abstract][Full Text] [Related]
4. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Jun; 23(11):3416-20. PubMed ID: 23591110
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a novel series of histamine H3 receptor antagonists through a scaffold hopping strategy.
Gao Z; Hurst WJ; Hall D; Hartung R; Reynolds W; Kang J; Nagorny R; Hendrix JA; George PG
Bioorg Med Chem; 2015 Feb; 23(3):429-38. PubMed ID: 25577710
[TBL] [Abstract][Full Text] [Related]
6. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Jun; 23(11):3421-6. PubMed ID: 23591112
[TBL] [Abstract][Full Text] [Related]
7. Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
Brown DG; Bernstein PR; Griffin A; Wesolowski S; Labrecque D; Tremblay MC; Sylvester M; Mauger R; Edwards PD; Throner SR; Folmer JJ; Cacciola J; Scott C; Lazor LA; Pourashraf M; Santhakumar V; Potts WM; Sydserff S; Giguère P; Lévesque C; Dasser M; Groblewski T
J Med Chem; 2014 Feb; 57(3):733-58. PubMed ID: 24410637
[TBL] [Abstract][Full Text] [Related]
8. Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
de Lera Ruiz M; Zheng J; Berlin MY; McCormick KD; Aslanian RG; West R; Hwa J; Lachowicz J; van Heek M
Bioorg Med Chem Lett; 2013 Nov; 23(21):6004-9. PubMed ID: 24035485
[TBL] [Abstract][Full Text] [Related]
9. KSK19 - Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice.
Kotańska M; Mika K; Reguła K; Szczepańska K; Szafarz M; Bednarski M; Olejarz-Maciej A; Nowak K; Latacz G; Mogilski S; Kuder KJ; Kieć-Kononowicz K; Sapa J
Biochem Pharmacol; 2019 Oct; 168():193-203. PubMed ID: 31295465
[TBL] [Abstract][Full Text] [Related]
10. New lead elements for histamine H
Espinosa-Bustos C; Frank A; Arancibia-Opazo S; Salas CO; Fierro A; Stark H
Bioorg Med Chem Lett; 2018 Sep; 28(17):2890-2893. PubMed ID: 30025902
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H
Szczepańska K; Karcz T; Mogilski S; Siwek A; Kuder KJ; Latacz G; Kubacka M; Hagenow S; Lubelska A; Olejarz A; Kotańska M; Sadek B; Stark H; Kieć-Kononowicz K
Eur J Med Chem; 2018 May; 152():223-234. PubMed ID: 29723785
[TBL] [Abstract][Full Text] [Related]
12. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
Le S; Gruner JA; Mathiasen JR; Marino MJ; Schaffhauser H
J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists.
Josef KA; Aimone LD; Lyons J; Raddatz R; Hudkins RL
Bioorg Med Chem Lett; 2012 Jun; 22(12):4198-202. PubMed ID: 22617490
[TBL] [Abstract][Full Text] [Related]
14. A Versatile Sub-Nanomolar Fluorescent Ligand Enables NanoBRET Binding Studies and Single-Molecule Microscopy at the Histamine H
Rosier N; Grätz L; Schihada H; Möller J; Işbilir A; Humphrys LJ; Nagl M; Seibel U; Lohse MJ; Pockes S
J Med Chem; 2021 Aug; 64(15):11695-11708. PubMed ID: 34309390
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Gao Z; Hurst WJ; Czechtizky W; Francon D; Griebel G; Nagorny R; Pichat P; Schwink L; Stengelin S; Hendrix JA; George PG
Bioorg Med Chem Lett; 2013 Nov; 23(22):6141-5. PubMed ID: 24076172
[TBL] [Abstract][Full Text] [Related]
16. Histamine H3-receptor inverse agonists as novel antipsychotics.
Ito C
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):132-6. PubMed ID: 20021346
[TBL] [Abstract][Full Text] [Related]
17. Using electrophysiology and in silico three-dimensional modeling to reduce human Ether-à-go-go related gene K(+) channel inhibition in a histamine H3 receptor antagonist program.
Davenport AJ; Möller C; Heifetz A; Mazanetz MP; Law RJ; Ebneth A; Gemkow MJ
Assay Drug Dev Technol; 2010 Dec; 8(6):781-9. PubMed ID: 21133680
[TBL] [Abstract][Full Text] [Related]
18. Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice.
Nuutinen S; Mäki T; Rozov S; Bäckström P; Hyytiä P; Piepponen P; Panula P
Neuropharmacology; 2016 Jul; 106():156-63. PubMed ID: 26107118
[TBL] [Abstract][Full Text] [Related]
19. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats.
Sadek B; Saad A; Latacz G; Kuder K; Olejarz A; Karcz T; Stark H; Kieć-Kononowicz K
Drug Des Devel Ther; 2016; 10():3879-3898. PubMed ID: 27932863
[TBL] [Abstract][Full Text] [Related]
20. Histamine H3 receptor antagonists - Roles in neurological and endocrine diseases and diabetes mellitus.
Abdulrazzaq YM; Bastaki SMA; Adeghate E
Biomed Pharmacother; 2022 Jun; 150():112947. PubMed ID: 35447544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
